These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 16257362
21. Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews. Brenner B, Fried G, Levitzki P, Rakowsky E, Lurie H, Idelevich E, Neuman A, Kaufman B, Sulkes J, Sulkes A. Cancer; 2002 Apr 15; 94(8):2128-33. PubMed ID: 12001108 [Abstract] [Full Text] [Related]
33. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer. Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kücücük S, Aslay I, Aydiner A, Topuz E. Cancer Invest; 2008 Aug 01; 26(7):671-9. PubMed ID: 18608215 [Abstract] [Full Text] [Related]
35. Changing patterns in breast cancer incidence trends. Holford TR, Cronin KA, Mariotto AB, Feuer EJ. J Natl Cancer Inst Monogr; 2006 Aug 01; (36):19-25. PubMed ID: 17032890 [Abstract] [Full Text] [Related]
36. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group. J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604 [Abstract] [Full Text] [Related]
37. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement. Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK. J Natl Cancer Inst; 2007 Jul 04; 99(13):1044-9. PubMed ID: 17596573 [Abstract] [Full Text] [Related]
39. Differences between male and female breast cancer. II. Clinicopathologic features. Rudan I, Rudan N, Basić N, Basić V, Rudan D. Acta Med Croatica; 1997 Jul 04; 51(3):129-33. PubMed ID: 9248109 [Abstract] [Full Text] [Related]